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Vaccinia virus (VACV) C7L is a host-range gene that regulates cellular tropism of VACV. Distantly related C7L homologues are encoded by
nearly all mammalian poxviruses, but whether they are host-range genes functioning similar to VACV C7L has not been determined. Here, we used
VACV as a model system to analyze five different C7L homologues from diverse mammalian poxviruses for their abilities to regulate poxvirus
cellular tropism. Three C7L homologues (myxoma virus M63R, M64R and cowpox virus 020), when expressed with an epitope tag and from a
VACVmutant lacking the host-range genes K1L and C7L (vK1L−C7L−), failed to support productive viral replication in human andmurine cells. In
nonpermissive cells, these viruses did not synthesize viral late proteins, expressed a reduced level of the early protein E3L, and were defective at
suppressing cellular PKR activation. In contrast, two other C7L homologues, myxoma virus (MYXV) M62R and yaba-like disease virus (YLDV)
67R, when expressed with an epitope tag and from vK1L−C7L−, supported normal viral replication in human andmurine cells and restored the ability
of the virus to suppress PKR activation. Furthermore, M62R rescued the defect of vK1L−C7L− at replicating and disseminating in mice following
intranasal inoculation. These results show that MYXV M62R and YLDV 67R function equivalently to C7L at supporting VACV replication in
mammalian hosts and suggest that a C7L-like host-range gene is essential for the replication of many mammalian poxviruses in mammalian hosts.
© 2007 Elsevier Inc. All rights reserved.Keywords: Poxvirus; Vaccinia virus; Myxoma virus; C7L; Host-range; PKRIntroduction
Poxviruses are a family of complex, double-stranded DNA
viruses that replicate entirely in the cytoplasm (Moss, 2001).
Members of the poxvirus family infect a wide variety of hosts,
including insects, reptiles, birds, and mammals. The poxviruses
that infect mammals are classified into seven genera, among
which the orthopoxvirus genus has the greatest impact on
human health. Orthopoxviruses include variola virus, mon-
keypox virus, cowpox virus and vaccinia virus (VACV).
Variola virus causes smallpox, for which VACV serves as an
effective vaccine. VACV has a broad host-range, infecting
many mammalian species. Most other mammalian poxviruses
have a narrower host-range, but many of them could infect cell
lines derived from diverse mammalian species. For instance,
myxoma virus (MYXV) of the leporipoxvirus genus has a
limited host-range in rabbit, but it can replicate in many⁎ Corresponding author. Fax: +1 210 567 6612.
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doi:10.1016/j.virol.2007.10.023transformed human cell lines and has been tested as an
oncolytic agent (Lun et al., 2005). In contrast, avian poxviruses
replicate abortively in mammalian cells, although they are
capable of gaining entry and expressing a limited set of viral
genes in mammalian cells (Somogyi et al., 1993). Indeed,
unlike most other viruses, cellular tropism of poxviruses does
not appear to be limited by the availability of specific receptors
on host cell surface but by some intracellular factors (reviewed
by McFadden, 2005).
The identities of the intracellular factors that determine
poxvirus cellular tropism are unknown, but poxvirus genes that
are required for viral replication in specific mammalian cell
types have been identified from orthopoxviruses and myxoma
virus (McFadden, 2005). Among these so-called “host-range”
genes, K1L and C7L of VACV affect the widest range of cell
lines (Perkus et al., 1990). The deletion of K1L and C7L from
VACV results in abortive replication of the mutant in most
mammalian cell lines, while it has no effect on viral replication
in avian cells and a few specific mammalian cell lines (Drillien
et al., 1981; Gillard et al., 1986; Perkus et al., 1990). The
Table 1
Percentage identity and similarity between C7L and its homologues from mammalian poxviruses
VACV C7La MYXV M62R YLDV 67R SPPV 063 SWPV 064 DPV 076 MYXV M63R MYXV M64R CPXV 020
VACV C7L a 27 (42) b 28 (45) 24 (39) 28 (41) 25 (37) 13 (25) 16 (33) 26 (41)
MYXV M62R 37 (48) 30 (43) 35 (45) 29 (43) 20 (36) 30 (43) 16 (28)
YLDV 67R 40 (51) 42 (58) 39 (55) 24 (39) 28 (43) 23 (37)
SPPV 063 44 (56) 56 (65) 20 (41) 30 (44) 18 (32)
SWPV 064 42 (59) 21 (36) 31 (49) 17 (32)
DPV 076 29 (57) 28 (45) 16 (29)
MYXV M63R 20 (36) 14 (27)
MYXV M64R 15 (29)
a The names of the ORFs are as described in the legend to Fig. 1.
b The number outside and inside the parenthesis indicates the percentage identity and similarity between the two compared amino acid sequences, respectively.
373X. Meng et al. / Virology 372 (2008) 372–383replication block of the mutant was shown to occur at the
translation of intermediate stage viral mRNA in human HeLa
cells (Hsiao et al., 2004). NYVAC, a host-range-restricted
VACV strain lacking 18 genes including K1L and C7L, has
been developed as a safe vaccine vector for infectious diseases
and cancer (Tartaglia et al., 1992). The replication defect of
K1L- and C7L-deficient VACV can be complemented in human
cells by either K1L or C7L or the cowpox virus CP77 gene,
while its defect in rabbit RK13 cells can be complemented by
either K1L or CP77 but not by C7L (Perkus et al., 1990;
Ramsey-Ewing and Moss, 1996). K1L was shown to prevent
the degradation of IκBα and thus inhibit host NF-κB activation
in rabbit RK-13 (Shisler and Jin, 2004). Both K1L and CP77
contain multiple ankyrin repeats, which typically serves as a
structural scaffold for mediating protein–protein interactionsFig. 1. A multiple-sequence alignment of C7L and its homologues from mammal
(myxoma virus, leporipoxvirus) M62R, YLDV (Yaba-like diseases virus, yatapoxvi
suipoxvirus) 064, DPV (deerpox virus, unclassified) 076, MYXVM63R, MYXVM6
or similar in five or more of the nine proteins are highlighted. The dark and light sh(Sedgwick and Smerdon, 1999). K1L is able to bind ACAP2
(Bradley and Terajima, 2005), a GTPase-activating protein for
ARF6, but this ability does not appear to be required for K1L's
host-range function (Meng and Xiang, 2006). CP77 is able to
interact with a cellular protein HMG20A (Hsiao et al., 2006).
However, the exact mechanism by which K1L, C7L or CP77
control VACV cellular tropism remains elusive.
Among these poxvirus host-range genes, the C7L gene
appears to be the most conserved in mammalian poxviruses. The
CP77 gene is only present in cowpox virus and monkeypox
virus, while the K1L gene is present in a few orthopoxviruses
including VACV, cowpox virus and monkeypox virus. They are
either absent or fragmented in other orthopoxviruses. In contrast,
an ORF that is almost identical to VACV C7L is present in the
genome of every orthopoxvirus. Furthermore, homologues thatian poxviruses. They are VACV (vaccinia virus, orthopoxvirus) C7L, MYXV
rus) 67R, SPPV (sheeppox virus, capripoxvirus) 063, SWPV (swinepox virus,
4R and CPXV (cowpox virus, orthopoxvirus) 020. Amino acids that are identical
ading indicate amino acids that are identical or similar, respectively.
374 X. Meng et al. / Virology 372 (2008) 372–383are distantly related to VACV C7L are found in nearly all
sequenced mammalian poxviruses except molluscum contagio-
sum virus and parapoxviruses. However, whether these C7L
homologues are host-range genes functioning similarly to
VACV C7L is unknown. In this study, we analyzed 5 distantly
related C7L homologues from diverse mammalian poxviruses
and found that MYXVof the leporipoxvirus genus and Yaba-like
disease virus (YLDV) of the yatapoxvirus genus encode a gene
that functions equivalently to VACV C7L, suggesting that a
C7L-like host-range gene is essential for productive replication
of many mammalian poxviruses in mammalian hosts.
Results
Many mammalian poxviruses encode putative C7L homologues
A direct counterpart for VACV C7L gene is present in the
genome of every orthopoxvirus. In addition, some orthopox-
viruses, including cowpox virus (CPXV) and camelpox virus,
encode a putative protein that is 26% identical to the C7L
protein. This C7L homologue is represented by open reading
frame (ORF) 020 of CPXV strain Brighton Red. Besides
orthopoxviruses, nearly all other sequenced mammalian pox-
viruses encode putative C7L homologues. In particular, myxo-
ma virus (MYXV) encodes three C7L homologues in
neighboring ORFs (M62R, M63R and M64R), which are
13% to 27% identical to the C7L protein. Other C7L homo-
llogues include ORF 67R of Yaba-like disease virus (YLDV),
which is 28% identical to the C7L protein. The similarities
between C7L and its homologues from several different
poxvirus genera are listed in Table 1 and shown by their
multiple amino acid sequence alignment in Fig. 1. Compared to
VACV C7L, all C7L homologues have additional C-terminal
tails that share very little sequence similarity among each other
except that they all contain many acidic residues. MYXVM63R
has an additional 24-amino acid internal insertion that is absent
from other C7L homologues. Unlike CP77 and K1L, C7L and
its homologues contain no ankyrin repeat, as assessed by the
REP program (http://www.embl-heidelberg.de/~andrade/
papers/rep/search.html) (Andrade et al., 2000). No C7L homo-
logue was found outside the poxvirus family.
Construction of recombinant VACV with its K1L deleted and its
C7L substituted with a C7L homologue
In the absence of the K1L gene, VACV depends on C7L to
provide an essential function to replicate productively in humanFig. 2. Construction of recombinant VACV with its K1L deleted and its C7L substit
genomic organization of the recombinant VACV. The construction of K1L and C7L d
Recombinant VACVencoding the C7L homologue were constructed by homologous
the green fluorescence protein (GFP). P11 indicates the VACV promoter that normall
and C) The recombinant VACVexpresses the expected C7L homologue. VERO cells
viruses, which are referred by the name of ORF present at the C7L locus. The C7L ho
level of C7L homologue in infected cells was determined by Western blot with a mon
the right to illustrate the weaker band. On the same blot, the levels of VACV early p
polyclonal antiserum and an anti-Hsp70 mAb. Hsp70 serves as a control for gel loadi
of the molecular weight marker in kilodaltons is shown on the left. The predicted mcells (Perkus et al., 1990). Therefore, to determine whether any
C7L homologue could perform the same function as VACV
C7L, we constructed recombinant VACV with its K1L deleted
and its C7L substituted with a C7L homologue. The viruses
were constructed by placing the coding sequence for the C7L
homologue into the C7L locus of vK1L−C7L−, a previously
constructed virus with precise deletion of K1L and C7L genes
(Meng and Xiang, 2006) (Fig. 2A). Five representative C7L
homologues, YLDV 67R, CPXV 020 and MYXV M62R,
M63R and M64R, were chosen to substitute C7L. Through
homologous recombination, each C7L homologue, along with a
C-terminal tag and an adjacent selective marker consisting of
the green fluorescent protein (GFP) controlled by a late stage
promoter, was placed immediate downstream of the C7L
promoter so that its expression was controlled by the authentic
C7L promoter (Fig. 2A). For all the C7L homologues, their C-
terminal tag has the V5 epitope to facilitate their detection. For
YLDV 67R and CPXV 020, their C-terminal tag includes the
additional calmodulin-binding domain and biotin binding
domain (referred together as V5-TAP tag), intended to facilitate
their tandem affinity purification. As controls, recombinant
viruses encoding C7L with either a V5 or a V5-TAP tag were
constructed similarly. All the recombinant viruses were isolated
on VERO cells where they form normal-size plaques (shown
later). The viruses are referred hereafter by the name of the ORF
present at the original C7L locus of the virus.
To assess whether the recombinant viruses expressed the
expected C7L homologue, VERO cells were infected with the
viruses at a multiplicity of infection (MOI) of 10 PFU per cell,
and then the cell lysates were analyzed by immunoblot. A
protein band that is consistent with the predicated molecular
mass of the respective C7L homologue was detected by anti-
V5 antibody from cells that were infected by the recombinant
viruses (Fig. 2B). The signal for YLDV 67R and CPXV 020
proteins, which were tagged with V5-TAP, was significantly
weaker than that for the other C7L homologues, which were
tagged with V5 epitope. This was not due to a reduced viral
protein synthesis by the particular recombinant viruses, as the
expression level of another VACV early protein E3L was
similar for all the viruses. The signal for C7L tagged with V5-
TAP was also weaker than that for C7L tagged with V5 only
(data not shown), so the TAP tag sequence C-terminal to the
V5 epitope probably made the protein less stable or less
detectable by anti-V5 antibody in immunoblot. C7L, YLDV
67R and CPXV 020 that were tagged with V5-TAP were
better detected when the cells were infected at a higher MOI
(Fig. 2C).uted with a C7L homologue. (A) Schematic illustration of the construction and
eletion mutant vK1L−C7L− was described previously (Meng and Xiang, 2006).
recombination of vK1L−C7L− and a plasmid encoding the C7L homologue and
y regulates late expression of the gene encoding the 11K protein (WR F18R). (B
were infected at a MOI of 10 PFU (B) or 25 PFU (C) per cell with the indicated
mologue is tagged at its C-terminus with either a V5 or V5-TAP tag. At 8 hpi, the
oclonal antibody (mAb) against V5. A longer exposure of the blot was shown on
rotein E3L and host cell protein Hsp70 were also determined with an anti-E3L
ng, while E3L serves as an indicator of VACVearly protein expression. The size
olecular weights of the tagged C7L homologues are listed on the right.
375X. Meng et al. / Virology 372 (2008) 372–383YLDV 67R and MYXV M62R can substitute C7L for its
function in human and murine cell lines while CPXV 020,
MYXV M63R and M64R cannot
To determine whether the C7L homologues could function as
a host-range gene for VACV, the abilities of the recombinantviruses to form plaques on various human and murine cell lines
were analyzed. A-431, an epidermoid carcinoma cell line, and
HeLa, a cervix adenocarcinoma cell line, were chosen as
representative human cells. 3T3, an embryonic fibroblast cell
line, was chosen as representative murine cells. On these cell
types, the parental vK1L−C7L− did not form plaque (data not
Fig. 3. YLDV 67R and MYXV M62R can substitute C7L for its function in human and murine cell lines while CPXV 020, MYXV M63R and M64R cannot.
(A) Plaque morphology of the recombinant VACVon representative cell lines. VERO, 3T3, HeLa and A431 cells were infected at a MOI of 0.01 PFU/cell with the
indicated viruses. At approximately 36 hpi, GFP-expressing cells were visualized with an inverted fluorescence microscope using a 10× objective and photographed.
(B) Growth curves of the recombinant VACV in HeLa cells at MOI of 5 PFU/cell. Virus yields at 0, 24 and 48 hpi were determined by plaque assay on the permissive
VERO cells. The growth curves of the recombinant VACV in 3T3 and A431 were similar to the ones in HeLa cells and thus not shown.
376 X. Meng et al. / Virology 372 (2008) 372–383shown), but vVACV-C7L, encoding either the V5 or V5-TAP
tagged C7L, formed normal-size plaques (Fig. 3A and data not
shown), indicating that the tagged C7L protein is functional in
murine as well as in human cells. vYLDV-67R and vMYXV-
M62R also formed normal-size plaques on these cells, while
vCPXV-020, vMYXV-M63R and vMYXV-M64R did not form
any plaque (Fig. 3A), indicating that only YLDV 67R and
MYXVM62R can function as a C7L-like host-range gene. This
is further demonstrated by one-step growth analysis, which
showed that vYLDV-67R and vMYXV-M62R replicated as
efficiently as vVACV-C7L in human and murine cells (Fig. 3B
and data not shown). None of the recombinant viruses was able
to replicate productively in rabbit RK-13 cell (data not shown),
indicating that YLDV 67R and MYXV M62R, similar to C7L,
were not able to substitute K1L for the host-range function in
RK-13 cells.Host-range-restricted viruses did not synthesize viral late
proteins and expressed a reduced level of the early protein E3L
in nonpermissive cells
In nonpermissive murine and human cells, vCPXV-020,
vMYXV-M63R and vMYXV-M64R did not express GFP that
was controlled by the late P11 promoter (Fig. 3A), suggesting
that their late protein synthesis is defective. To further charac-
terize the step at which the replication of these host-range-
restricted viruses was blocked, HeLa cells were infected by the
recombinant viruses for various times and then subjected to
immunoblots. At 8 hours post infection (hpi), the C7L protein or
its homologue was detected for all viruses except vCPXV-020,
whose expression of CPXV 020 in the permissive VERO cells
was also difficult to detect (Fig. 4). Similarly, VACV early
protein E3L was expressed by all the viruses. At 12 hpi, the
Fig. 4. vMYXV-M63R, vMYXV-M64R and vCPXV-020 are defective at viral
late protein synthesis in nonpermissive HeLa cells. HeLa cells were infected
with the indicated viruses at MOI of 10 PFU/cell. At 8 hpi, the level of viral early
proteins C7L (or its homologue) and E3L were determined by Western blot as
described in Fig. 2B. At 12 hpi, the level of a VACV late protein encoded by
ORF WR148 (11) was determined by Western blot with a mAb against WR148.
WR148 is a remnant of orthopoxvirus A-type inclusion (ATI) protein.
377X. Meng et al. / Virology 372 (2008) 372–383VACV late protein encoded by ORF WR148 (Jones-Trower
et al., 2005), a remnant of orthopoxvirus A-type inclusion (ATI)
protein, was abundantly expressed by the replication competent
viruses (vVACV-C7L, vMYXV-M62R and vYLDV-67R), but it
was not expressed at all by the host-range-restricted viruses
(vCPXV-020, vMYXV-M63R and vMYXV-M64R), demon-
strating a defect of the host-range-restricted viruses at late
protein synthesis in nonpermissive cells.
To define more precisely the difference in viral protein
expression in permissive and nonpermissive cells by the host-
range-restricted viruses, a time course of viral protein
expression was determined for vMYXV-M64R and vVACV-
C7L. In the permissive VERO cells, the M64R protein was
detected as early as 2 hpi, and its amount increased over time up
to 12 hpi (Fig. 5A). This time course was similar to that of E3L.
In contrast, VACV late protein WR148 was not detected until
8 hpi but its amount increased up to 24 hpi when the infection
was stopped. A similar time course of viral protein expression
was observed for vVACV-C7L. In nonpermissive HeLa cells,
however, vMYXV-M64R did not express WR148 and
expressed E3L at a reduced level (Fig. 5B). At 2 hpi, the
level of E3L protein was similarly low in vMYXV-M64R- and
vVACV-C7L-infected cells. While the level of E3L protein in
vVACV-C7L-infected HeLa cells continued to increase up to
8 hpi, its level in vMYXV-M64R-infected cells decreased after
4 hpi, indicating that vMYXV-M64R is defective at sustaining
E3L protein synthesis. The level of M64R in vMYXV-M64R-
infected cells continued to increase up to 8 hpi, suggesting thatthe expression of different viral early genes by vMYXV-M64R
is affected by different degrees in nonpermissive cells.
The role of C7L in VACV-mediated suppression of cellular
PKR and eIF2-α activities
It was previously reported that VACV mutants with neither
K1L nor C7L genes induce PKR and eIF2-α phosphorylation in
HeLa cells and that restoring C7L or CP77 to the mutants could
prevent the phosphorylation (Hsiao et al., 2004; Najera et al.,
2006). However, it was unclear how C7L or CP77 affects PKR
and eIF2-α phosphorylation and whether this effect contributes
to the ability of C7L and CP77 to support viral protein
translation. The E3L protein is a well-known inhibitor of PKR
and the consequent eIF2-α phosphorylation (Langland and
Jacobs, 2004). As we found that C7L was required for
sustaining E3L expression in HeLa cells, we then performed
experiments to assess whether the effect of C7L on cellular PKR
and eIF2-α phosphorylation could be attributed to its effect on
E3L expression. First, we determined the time courses of PKR
and eIF2-α phosphorylation in vMYXV-M64R- or vVACV-
C7L-infected HeLa cells by immunoblotting with antibodies
against total and phosphorylated PKR and eIF2-α. At 4 hpi,
while phospho-PKR was not detected in vVACV-C7L-infected
cells, it appeared in vMYXV-M64R-infected cells (Fig. 6A). No
difference in the level of phospho-eIF2-α was observed at this
time point. At 8 and 12 hpi, an increasing amount of phospho-
PKR was detected in vMYXV-M64R-infected cells. Concom-
itantly, there was an increase in the amount of phospho-eIF2-α
in the cells. In contrast, the amount of phospho-PKR and
phospho-eIF2-α were relatively lower in vVACV-C7L infected
cells at these time points. This result, taken together with the
time course of E3L expression shown in Fig. 5B, indicates that
the difference in the level of phospho-PKR and phospho-eIF2-α
in vVACV-C7L- and vMYXV-M64R-infected HeLa cells
correlates closely with the difference in the level of E3L protein
in the cells.
Next, to determine the effect of C7L homologues on PKR
activation, we infected HeLa cells with viruses expressing
different C7L homologues for 4 h and then assessed the level of
phospho-PKR (Fig. 6B). In cells that are mock-infected or
infected with replication competent virus (vVACV-C7L,
vMYXV-M62R or vYLDV-67R), very little phospho-PKR
was detected. In contrast, phospho-PKR was clearly detected in
cells that were infected with host-range-restricted viruses
(vMYXV-M63R, vMYXV-M64R and vCPXV-020). The level
of E3L proteins in these cells was also significantly lower than
that in cells infected by replication competent viruses. This
result shows that MYXV M62R and YLDV 67R can substitute
C7L for its effect on the inhibition of PKR phosphorylation and
is again consistent with the idea that C7L affects PKR
phosphorylation indirectly through its effect on E3L expression.
In an effort to find additional cellular pathways that are
affected by C7L-like host-range genes, we tested the effects of
the recombinant viruses on several signaling molecules that are
related to cellular growth and protein translation. HeLa cells
were infected by the viruses for 4 h. Then, the cellular level of
Fig. 5. The temporal expression of viral proteins by vVACV-C7L and vMYXV-M64R in VERO and HeLa cells. VERO (A) and HeLa cells (B) were infected at a MOI
of 10 PFU per cell with vVACV-C7L or vMYXV-M64R. At the indicated time after infection (hpi), the level of C7L or M64R proteins was determined byWestern blot
with an anti-V5 antibody. The levels of VACV proteins E3L,WR148 and host cell protein Hsp70 were also determined byWestern blot as respective control for VACV
early, late protein expression and gel loading.
378 X. Meng et al. / Virology 372 (2008) 372–383phospho-p90RSK, phospho-Akt, phospho-p44/42 mitogen-
activated protein kinase, phospho-S6 ribosomal protein, and
total eIF4E were determined together with a multiplex of
antibodies in immunoblot (Fig. 6C). The level of total eIF4E
was similar for mock- and virus-infected cells, indicating equal
amount of proteins loaded on the gel. No or very low level of
phospho-Akt was detected in the cells during repeated experi-
ments. The levels of phospho-S6 ribosomal protein, phosphor-
ylated p44/42 and its downstream effector p90RSK were
elevated in virus-infected cells. Since the phosphorylation of
these molecules was equally induced by all the recombinant
VACVs, C7L is unlikely to play any role in this process and thus
this phenomenon was not investigated further. Nevertheless,this experiment served as a control demonstrating that PKR is a
specific pathway that is affected by the presence of C7L-like
host-range gene in VACV.
vMYXV-M64R is highly attenuated in a mouse intranasal
infection model while vMYXV-M62R is virulent
To assess whether the ability of the C7L homologue to
support VACV replication in cell lines correlates with an ability
to support VACV replication in animal hosts, the relative
virulence of vVACV-C7L, vMYXV-M62R and vMYXV-M64R
was determined with a mouse model. Mice were infected
intranasally with 105 PFU of purified viruses and monitored
Fig. 6. The defect of the host-range restricted viruses at suppressing cellular PKR and eIF2-α phosphorylation in HeLa cells correlates with a defect of the viruses at
maintaining E3L expression. (A) The same cell lysates as described in Fig. 5B were used to determine the levels of total and phosphorylated PKR and eIF2-α proteins
in HeLa cells that were infected with vVACV-C7L or vMYXV-M64R for various time. The level of phosphorylated PKR and eIF2-α proteins were determined by
Western blot with mAbs against phospho-PKR (Thr446) and phospho-eIF2α (Ser51). The blot was then stripped, and the levels of total PKR and eIF2-α were
determined by Western blot with a mAb against total PKR and a polyclonal antibody against total eIF2-α. (B) HeLa cells were infected with the indicated viruses for
4 h and the level of total and phosphorylated PKR and VACV E3L proteins were determined by Western blot. (C) The same samples as shown in B were analyzed by
Western blot with a multiplex of antibodies, including antibodies against phospho-p90RSK (Ser-308), phospho-Akt (Ser-473), phospho-p44/42 mitogen-activated
protein kinase (Thr-202/Tyr-204), phospho-S6 ribosomal protein (Ser-235/236), and total eIF4E.
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Fig. 7. vMYXV-M64R is highly attenuated in a mouse intranasal infection
model while vMYXV-M62R is virulent. (A) Groups of 5 Balb/c mice were
infected intranasally with 105 PFU of indicated viruses or mock infected with the
same volume of PBS. The mice were then monitored daily for their body
weights. For each group, the average of the percentage of body weight change
and standard deviation are shown. (B) At day 7 post infection, mice were
euthanized and their lungs and spleen were harvested. Approximately 16 mg of
spleen and 5 mg of lung from each mouse were homogenized and their viral
loads were determined by plaque assay on VERO cells. Error bars represent
standard deviation.
380 X. Meng et al. / Virology 372 (2008) 372–383daily for their body weights (Fig. 7A). Similar to mock-infected
mice, vMYXV-M64R-infected mice gained some weight by
day 5 post infection, indicating that vMYXV-M64R is highly
attenuated and does not cause disease in mice. In contrast, both
vVACV-C7L- and vMYXV-M62R-infected mice lost close to
30% of their original body weight by day 5 post infection
(Fig. 7A), when they were euthanized and the viral loads in their
organs were determined. While the mice infected by vMYXV-
M64R had no detectable level of virus in their organs (data not
shown), the mice infected by either vVACV-C7L or vMYXV-
M62R had a similarly high level of virus in their lung and spleen
(Fig. 7B), indicating that MYXV M62R can substitute VACV
C7L at supporting VACV replication and dissemination in vivo
while M64R cannot. In a separate experiment, the VACV
mutant with a deletion in K1L and C7L, which was the parental
virus for vVACV-C7L, vMYXV-M62R and vMYXV-M64R,
was found to be highly attenuated in mice (data not shown),
similar to vMYXV-M64R.Discussion
Our current understanding of the mechanism by which
poxvirus host tropism is controlled came mainly from the
identification and analysis of poxvirus host-range genes.
Previously, different sets of host-range genes were identified
for orthopoxviruses and leporipoxviruses, suggesting that
poxviruses of different genera may have evolved their own
unique sets of host-range genes to adapt to their unique host
environment. In this study, however, we found that the function
encoded by VACV host-range gene C7L is not limited to
orthopoxviruses and is not specific for host interaction in human
cell lines as previous studies suggested (Perkus et al., 1990). We
found that myxoma virus and Yaba-like disease virus both
encode a gene that functions equivalently to VACV C7L,
suggesting that C7L is a poxvirus host-range gene whose
function is essential for the replication of many mammalian
poxviruses in mammalian hosts.
We characterized five distantly related C7L homologues and
found that two of these,MYXVM62R andYLDV67R, function
equivalently to VACV C7L, while three others, MYXV M63R,
M64R and CPXV 020, do not. Among the latter three, CPXV
020 was expressed at a reduced level by our recombinant VACV,
so the possibility that a higher level of CPXV 020 could have
provided a C7L-like function for poxvirus cannot be ruled out.
However, it would have been redundant for CPXV 020 to
encode a C7L-like function, since CPXV encodes a C7L
orthologue that is 97–100% identical to VACV C7L. The
identification of both functionally equivalent and non-equiva-
lent C7L homologues offers us an opportunity to examine other
poxvirus genomes for the presence of C7L-like host-range gene.
Although all C7L homologues have overall similar sequence
homology to C7L, we notice that the N-terminal 10 amino acid
of C7L are more conserved in functionally equivalent C7L
homologues (MYXV M62R and YLDV 67R) than in function-
ally non-equivalent C7L homologues (CPXV 020, MYXV
M63R and MYXV M64R). Whether these N-terminal residues
play any functional role remains to be determined, but it suggests
that sheeppox virus (SPPV) 063, swinepox virus (SWPV) 064
and deerpox virus (DPV) 076 may also function equivalently to
C7L, as their N-terminus 10 amino acids are more similar to C7L
than to the nonfunctional C7L homologues (Fig. 1). YLDV 67R
and MYXV M62R share more than 40% amino acid similarity
with each other and with SPPV 063, SWPV 064 and DPV 076
(Table 1). This level of sequence similarity is higher than that
between these C7L homologues and VACV C7L. Moreover, the
locations of SPPV 063, SWPV 064 and DPV 076 in the viral
genomes are identical to that of YLDV 67R and MYXVM62R.
All are present in the central region of the genome between the
genes encoding thymidine kinase and the polyA polymerase
regulatory protein. Thus, it appears that SPPV 063, SWPV 064
and DPV 076 are orthologues of YLDV 67R andMYXVM62R.
Interestingly, the genomic location of the C7L gene differs from
that of YLDV 67R or MYXV M62R. In orthopoxviruses, the
C7L gene locates near the left end of the genome, and there is no
ORF located between the genes encoding thymidine kinase and
the polyA polymerase regulatory protein.
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range gene in orthopoxviruses, leporipoxviruses, yatapox-
viruses, capripoxviruses, suipoxviruses and the unclassified
deerpox virus suggests that this gene does not confer species-
specific tropism to poxvirus, as these poxviruses have different
host-ranges in mammalian species. Rather, the C7L-like host-
range gene may represent an adaptation of mammalian
poxviruses to mammalian hosts, as it is not encoded by
avian poxviruses and not required for orthopoxviruses to
replicate in avian cells. Among all sequenced mammalian
poxviruses, the only viruses that do not encode a C7L
homologue are molluscum contagiosum virus (MCV) and
parapoxviruses. MCV has the narrowest host-range among
mammalian poxviruses. It infects human exclusively and
replicates only in keratinocytes in the basal epidermal layer of
the skin (Buller et al., 1995). MCV does not replicate in any
tissue culture cells. Parapoxviruses also have a limited host-
range, causing localized skin lesion in ruminants. In tissue
culture, they were usually propagated on primary muscle or
testis cells and can be adapted to propagate on some
mammalian cell lines including VERO cells (Fischer et al.,
2003). It is possible that the lack of a C7L-like host-range gene
may contribute to the very narrow host-range of these viruses
in mammalian cells.
We showed here that, in the absence of the K1L gene, C7L
or a C7L-like host-range gene is required for VACV to replicate
and disseminate in mice. As some orthopoxviruses including
variola virus do not have an intact K1L gene, our results
suggest that the variola virus ORF corresponding to C7L is
essential for variola virus to replicate in humans and thus cause
smallpox. Similarly, as no functional homologue of K1L has
been found outside the orthopoxviruses, the C7L-like host-
range gene in leporipoxviruses, yatapoxviruses, capripox-
viruses, suipoxviruses and deerpox virus is predicted to be
essential for the replication of these viruses in their respective
hosts. Among these viruses, myxoma virus is unique in that it
encodes three C7L homologues. M62R is shown here to
function equivalently to C7L, while M63R was recently found
to be a host-range gene that is essential for myxoma virus
replication in rabbits (Barrett et al., 2007). Our finding that
M63R cannot rescue the host-range defect of the K1L- and
C7L-deficient VACV is consistent with the previous report that
VACV K1L cannot rescue the host-range defect of M63R-
deficient myxoma virus (Barrett et al., 2007). M62R and M63R
may operate on two different cellular pathways that are both
essential for the replication of myxoma virus. While the cellular
pathway K1L/C7L/M62R operates on may be conserved in all
mammalian cells, the pathway M63R operates on may be more
specific to rabbit cells.
Our studies of K1L- and C7L-deficient VACV mutants
revealed a defect of the mutants at maintaining the synthesis
of VACV early protein E3L in nonpermissive cells. Previous
studies of a K1L- and C7L-deficient VACV mutant suggested
that the replication of the mutant in nonpermissive cells was
blocked at the stage of intermediate mRNA translation (Hsiao
et al., 2004). This was based on the finding that viral
intermediate and late proteins were not synthesized innonpermissive cells even though viral intermediate genes
were transcribed. The synthesis of viral early proteins was
presumed to be normal. In this study, we also found that viral
late proteins were not synthesized by our host-range mutants
in nonpermissive cells. In addition, we found that, while the
level of VACV early protein E3L accumulated up to 8 hpi in
HeLa cells infected by C7L positive VACV, its level in HeLa
cells infected by K1L- and C7L-deficient VACV was low and
did not increase after 4 hpi. We suggest that, in addition to a
defect in viral intermediate and late protein synthesis, K1L-
and C7L-deficient VACV also has a defect at maintaining viral
early protein synthesis. While this defect is quite pronounced
for the synthesis of E3L, it is subtle for C7L promoter directed
expression of MYXV M64R. This may due to a difference in
the mRNA levels of these two early genes, which may result
in their different susceptibility to the translational block.
Alternatively, it may due to a difference in the stability of their
gene products, which may result in an apparent difference in
the steady state protein levels. We speculate that the host-
range mutant gradually elicits a general translational block in
nonpermissive host cells and that the block reaches its full
effect when viral intermediate mRNAs are translated. This
may explain why the translational block may appear to affect
predominantly viral intermediate protein synthesis.
Our finding that viral early protein levels are affected by the
lack of a C7L-like host-range gene suggests that some of the
reported defects associated with K1L- and C7L-deficient
VACV may be the indirect consequence of reduced expression
of some viral early genes, which include many host response
modulators. Similar to previous reports (Hsiao et al., 2004;
Najera et al., 2006), we observed that K1L- and C7L-deficient
VACV mutants triggered PKR and eIF2-α phosphorylation in
nonpermissive cells and that restoring C7L can reverse this
phenotype. In addition, we found that MYXV M62R and
YLDV 67R can substitute C7L for the same effect, while
MYXV M63R, M64R and CPXV 020 cannot. This apparent
effect of C7L-like host-range genes on PKR and eIF2-α
phosphorylation appears to be specific as several other
signaling pathways, including ERK1/2 MAPK pathway, are
not affected. However, the inhibition of PKR and eIF2-α
phosphorylation is unlikely to be the mechanism by which
C7L-like host-range genes prevent a translational block on viral
proteins, as we observed a decrease in E3L protein level at
4 hpi, which coincides with PKR phosphorylation and precedes
eIF2-α phosphorylation. A more likely explanation is that PKR
and eIF2-α phosphorylation is the consequences of diminished
expression of E3L proteins by K1L- and C7L-deficient VACV.
Similarly, the reported induction of cellular apoptosis by K1L-
and C7L-deficient VACV (Hsiao et al., 2004; Najera et al.,
2006) may be another consequence of diminished expression of
viral early proteins, which include several inhibitors of
apoptosis. This is consistent with the fact that inhibiting
cellular apoptosis cannot rescue the host-range defect of the
mutants (Hsiao et al., 2004; Ink et al., 1995). The exact
mechanism by which CP77/K1L/C7L regulates poxvirus
tropism will have to await the identification of direct molecular
targets of these host-range genes.
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Cells and viruses
VERO (ATCC CCL-81), RK-13 (ATCC CCL-37) and CV-1
(ATCC CCL-70) cells were cultured in minimum essential
medium with Earle's balanced salts (Invitrogen) supplemented
with 10% fetal bovine serum (FBS). HeLa 229 (ATCCCCL-2.1),
A-431 (ATCCCRL-1555) andNIH/3T3 (ATCCCRL-1658) cells
were cultured in Dulbecco's modified Eagle's medium (Invitro-
gen)with 10%FBS.All recombinant VACVswere propagated on
VERO cells. Yaba-like disease virus (ATCC VR-937) was
obtained from ATCC and propagated on CV-1 cells.
Recombinant virus construction
Recombinant viruses used in this study were derived from
two viruses with similar deletions in K1L and C7L genes.
vK1L−C7L− was used initially in the study. It was derived from
vTF7.3 (Fuerst et al., 1986) as reported previously (Meng and
Xiang, 2006). WR.K1L−C7L− was used subsequently. It was
constructed identically to vK1L−C7L− except that the wild type
WR strain was used as the parental virus. WR.K1L−C7L−
behaves identically to vK1L−C7L− in tissue culture, but it has
the intact thymidine kinase (TK) gene, which is a virulence
factor for VACV in mice (Buller et al., 1985). All studies
involving mice were done withWR.K1L−C7L− derived viruses.
Viruses expressing V5-TAP-tagged C7L, YLDV 67R or
CPXV 020 ORF were derived from vK1L−C7L− through
homologous recombination with appropriate transfer plasmids.
Each transfer plasmid contains (i) 300 bp of downstream
flanking region of C7L, (ii) a GFP under the control of VACV
late promoter P11, (iii) ORF for C7L or its homologue with a C-
terminal V5 and TAP tag, and (iv) 300 bp of upstream flanking
region of C7L including the C7L promoter. The transfer
plasmids were assembled together through recombinant PCR
followed by cloning into pCR2.1 (Invitrogen). The GFP
cassette was derived from pYW31 (Meng and Xiang, 2006)
and was inserted between the downstream flanking region of
C7L and the stop codon for C7L (or its homologue). The TAP
tag was derived from pCTAP (Stratagene) and placed
immediately after the V5 tag and before the stop codon.
YLDV 67R or CPXV 020 ORF was derived from genomic
DNA of YLDVor CPXVand inserted immediately downstream
of the C7L promoter. The recombinant virus construction was
done according to standard protocols (Earl et al., 1998). Briefly,
lipofectamine 2000 (Invitrogen) was used to transfect the
transfer plasmids into VERO cells that had been infected with
vK1L−C7L−. Recombinant viruses expressing GFP were
picked under the fluorescence microscope and purified through
four rounds of plaque isolation on VERO cells.
Viruses expressing V5-tagged C7L, MYXV M62R, M63R
andM64R were constructed similarly as described above except
that WR.K1L−C7L− was used as the parental virus and only the
V5 tag was appended to C-terminus of C7L (or its homologue)
in the transfer plasmids. MYXV M62R, M63R and M64R were
derived from MYXV genomic DNA.To confirm that the recombinant viruses had the desired ORF
inserted at the C7L locus, viral DNAwas exacted from infected
cells (Qiagen Blood Kit) and the region of the viral genome from
300 bp downstream and 300 bp upstream of the original C7L
ORFwas PCR-amplified. The PCR product was further digested
with the restriction enzyme that recognized the inserted ORF.
Growth curve analysis
Cells in 12-well plates were incubated with 0.01 or 5 PFU
per cell of the viruses for 2 h at room temperature. Following
adsorption, the cells were washed twice with phosphate-
buffered saline (PBS) and moved to 37 °C incubator to initiate
viral entry and replication. The cells were harvest at 0, 24 and
48 hpi. The viral titers in the cell lysates were determined by
plaque assays on VERO cells. The results were confirmed by
repeating the same experiment one time. Infected cells
expressing GFP were also visualized under an inverted
fluorescence microscopy using a 10× objective and photo-
graphed with a digital camera.
Western blot analysis
The Western blot analysis was performed essentially as
described previously (Meng and Xiang, 2006). Briefly, the same
amount of cell lysates, as measured by Bradford protein assay,
were solubilized in sodium dodecyl sulfate (SDS) sample buffer,
resolved by SDS–polyacrylamide gel electrophoresis (PAGE),
transferred to nitrocellulose membranes, blocked, incubated
with appropriate antibodies and analyzed with chemilumines-
cence reagent (Pierce). The same membrane was sometimes
analyzed with additional antibodies after striping the membrane
with the Restore Western Blot Stripping Buffer (Pierce).
Antibodies
The mouse monoclonal antibody (mAb) against V5 was
obtained from Sigma-Aldrich. The mAbs against phospho-PKR
(Thr446), phospho-eIF2α (Ser51) and the PathScan Multiplex
Western Mixture I were from Cell Signaling technology. The
mAbs against PKR and Hsp70, and the polyclonal antibody
against total eIF2αwere from Santa Cruz biotechnology. Rabbit
anti-E3L polyclonal antiserum was a kind gift of Dr. Bertram
Jacobs. The mouse mAb against WR148 was from a hybridoma
developed with a WR-infected mouse (Meng X., G. Zhong and
Y. Xiang, unpublished observations).
Animals
Groups of five female BALB/c 5-week-old mice were
anesthetized and infected intranasally with 105 PFU of viruses
in 20 μl PBS. The viruses used were previously purified through
a sucrose cushion sedimentation according to the standard
protocol (Earl et al., 1998). Individual mice were weighed every
day. At day 7 post infection, all mice were euthanized and their
lung and spleen were harvested. The organs were homogenized
in 1.5-ml Eppendorf tube with a battery operated pestle grinder
383X. Meng et al. / Virology 372 (2008) 372–383(Fisher) and sonicated with a cup horn sonicator. Titration of
virus was done with VERO cells.
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